Emergency Medicine Reports - August 29, 2010

Target Audience:

This CME activity is intended for emergency physicians and family physicians.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.3 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
This activity is approved by the American College of Emergency Physicians for 2.25 hours of ACEP Category 1 credits.
 
Emergency Medicine Reports has been reviewed and is acceptable for up to 1.5 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins 01/01/10. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of each issue.

Faculty

Editors
Sandra M. Schneider, MD
Professor, Department of Emergency Medicine
University of Rochester School of Medicine
Rochester, New York

J. Stephan Stapczynski, MD

Chair
Emergency Medicine Department
Maricopa Medical Center
Phoenix, Arizona

CME Question Reviewer
Roger Farel, MD
Retired
Newport Beach, CA

Executive Editor
Russ Underwood

Specialty Editor
Shelley Mark

Authors
Sula Mazimba, MD, MPH,
Cardiology Fellow
Kettering Medical Center
Kettering, OH

Trupti Patel, MD
Jefferson School of Population Health
Philadelphia, PA

Nakash Grant, MD
Wright State University
Boonshoft School of Medicine
Dayton, OH.

Greg Wise, MD
Editor in chief of Primary Care Reports
Associate Professor of Medicine
Wright State University
Dayton, OH

Peer Reviewer
Thomas Hill, MD
Medical Director, Congestive Heart Failure Clinic
Mercy Health Partners
Muskegon, MI

Subjects:

  • Medical Advances in the Evaluation and Treatment of Heart Failure

Objectives:

  • Recognize or increase index of suspicion for specific conditions
  • State the epidemiology, etiology, pathophysiology, and clinical features of the entity discussed
  • Apply state-of-the-art diagnostic and therapeutic techniques (including the implications of pharmaceutical therapy discussed) to patients with the particular medical problems discussed.
  • Discuss the differential diagnosis of the entity discussed.
  • Explain both likely and rare complications that may occur.

Financial Disclosure:

To reveal any potential bias in this publication, and in accordance with Accreditation Council for Continuing Medical Education guidelines, we disclose that Sandra M. Schneider, MD (editor) serves on the editorial board for Logical Images. Roger Farel, MD (CME question reviewer) owns stock in Johnson & Johnson. Greg Wise, MD, (editor in chief of Primary Care Reports), Associate Professor of Medicine, Wright State University, Dayton, OH, serves on the speaker’s bureau and is a retained consultant for The Medicines Company. J. Stephan Stapczynski, MD (editor), Sula Mazimba, MD, MPH (author), Trupti Patel, MD, (author), Nakash Grant, MD (author), Thomas Hill, MD (peer reviewer), Russ Underwood (executive editor), and Shelley Mark (specialty editor) report no relationships with companies related to the field of study covered by this CME activity.

Copyright 2010 AHC Media. All rights reserved.